Online inquiry

IVTScrip™ mRNA-Human ANKRD46, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK19728MR)

This product GTTS-WK19728MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD46 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001270377.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 157567
UniProt ID Q86W74
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD46, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK19728MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK1477MR IVTScrip™ mRNA-Human CD63, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA CD63
GTTS-WK7732MR IVTScrip™ mRNA-Human ADGRB1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADGRB1
GTTS-WK24733MR IVTScrip™ mRNA-Human ARL11, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARL11
GTTS-WK20035MR IVTScrip™ mRNA-Human ANKRD66, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD66
GTTS-WK26893MR IVTScrip™ mRNA-Human ASB1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASB1
GTTS-WK22657MR IVTScrip™ mRNA-Human ARMC8, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARMC8
GTTS-WK18221MR IVTScrip™ mRNA-Human ANKRD36BP1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD36BP1
GTTS-WK21320MR IVTScrip™ mRNA-Human AHCYL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AHCYL1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW